NCT00996281View on ClinicalTrials.gov

Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension

PHASE3CompletedINTERVENTIONAL

Enrollment

837

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions

Essential Hypertension

Interventions

DRUG

Azilsartan medoxomil and chlorthalidone

Combination tablet.

DRUG

Olmesartan medoxomil and hydrochlorothiazide

Combination tablet.

Trial Locations (26)

Unknown

Graz

Karlsruhe

Hanover

Kiel-Kronshagen

Breda

Eindhoven

Amsterdam

Groningen

Velp

Leiderdorp

Rotterdam

Zoetermeer

Bydgoszcz

Skierniewice

Zgierz

Gdansk

Gdynia

Sopot

Mikołów

Avon

Bolton

Chorley

Inverness

Liverpool

Surrey

Warwickshire